We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (Generic Partners Pty Ltd)
Product name
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
244 working days (255)
Active ingredients
moxonidine
Registration type
New generic medicine
Indication
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (tablets) are indicated for the treatment of hypertension.